Repligen reported a solid first quarter with a revenue of $151 million. The company saw growth in the Filtration franchise excluding COVID and continued strength from new modality customers. The company is maintaining its adjusted 2024 financial guidance, expecting orders to pick up during the second half of the year.
First quarter revenue was reported as $151 million.
New modalities revenue increased by 16% year-over-year.
Filtration (non-COVID) revenue increased by 12% year-over-year.
A nine-month book-to-bill ratio of 1.03 was achieved.
Repligen reiterated its financial guidance for the full year 2024. The company expects total reported revenue between $620M - $650M.
Visualization of income flow from segment revenue to net income